Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and/or Bacterial vaginosis in pregnant women with Syphilis, Hepatitis B and/or Human immunodeficiency virus (HIV) infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250619008

Enrollment

133

Registered

2025-06-19

Start date

2023-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and/or Bacterial vaginosis in pregnant women with Syphilis, Hepatitis B and/or Human immunodeficiency virus (HIV) infection. Prevalence Chlamydia trachomatis Neisseria gonorrhoeae Bacterial vaginosis Syphilis Hepatitis B Human immunodeficiency virus infection pregnancy

Interventions

pregnant women with Syphilis and/or Hepatitis B and/or Human immunodeficiency virus (HIV) infection

Health Services Research

high risk pregnancy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women with Syphilis and/or Hepatitis B and/or Human immunodeficiency virus (HIV) infection between 1 January 2023 and 31 December 2025.

Exclusion criteria

Exclusion criteria: 1. Woman who could not provide data according to the case record form 2. Pregnant woman referred to other hospitals for delivery

Design outcomes

Primary

Measure	Time frame
Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and/or Bacterial vaginosis in pregnant women with Syphilis, Hepatitis B and/or Human immunodeficiency virus (HIV) infection 2023-2025 The number of high risk pregnant woman infected with Chlamydia trachomatis, Neisseria gonorrhoeae and/or Bacterial vaginosis.	—

Secondary

Measure	Time frame
Maternal risk factors and the adverse outcomes for both the mother and the newborn that may be associated with infections by Chlamydia trachomatis, Neisseria gonorrhea, and bacterial vaginosis. 2023-2025 The number of newborns with adverse outcomes, including an APGAR score below seven, NICU admission, respiratory support, or sepsis. Maternal risk factor are sociodemographic and behavioral factor.	—

Measure

Time frame

Maternal risk factors and the adverse outcomes for both the mother and the newborn that may be associated with infections by Chlamydia trachomatis, Neisseria gonorrhea, and bacterial vaginosis. 2023-2025 The number of newborns with adverse outcomes, including an APGAR score below seven, NICU admission, respiratory support, or sepsis. Maternal risk factor are sociodemographic and behavioral factor.

—

Countries

Thailand

Contacts

Public ContactKidakarn Jiratkitiwong

Mahidol University

kidakarn.jiratkitiwong@gmail.com0846401062

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026